Archived Grant Opportunity View - GO4228

The objective of the MRFF – Emerging Priorities and Consumer Driven Research – 2020 Medicinal Cannabis Clinical Trials Grant Opportunity is to support clinical trials that examine the effects of medicinal cannabis for the management of pain, symptoms and side-effects of cancer and cancer treatment in cancer patients.

The intended outcome of this grant opportunity is to build the evidence base to help medical professionals make informed decisions about the prescription of medicinal cannabis to manage and treat pain, symptoms and side-effects of cancer and cancer treatment.

Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available on GrantConnect and on the NHMRC website:

https://nhmrc.gov.au/funding/manage-your-funding/nhmrcs-administering-institutions

Applications must satisfy all the requirements set out in the MRFF – Emerging Priorities and Consumer Driven Research – 2020 Medicinal Cannabis Clinical Trials Grant Opportunity Guidelines 

Five years

$3,000,000.00

Applicants are advised to read the Grant Guidelines thoroughly and liaise with the Administering Institution that will submit the application to identify any specific requirements that the Institution might have.

Applications must be submitted electronically using NHMRC’s online Granting System (Sapphire).

Minimum Data closes at 5pm ACT local time on 28 October 2020.